-
Product Insights
NewNeuroendocrine Gastroenteropancreatic Tumors (GEP-NET) – Drugs In Development, 2024
Empower your strategies with our Neuroendocrine Gastroenteropancreatic Tumors (GEP-NET) – Drugs In Development, 2024 report and make more profitable business decisions. Gastroenteropancreatic neuroendocrine tumors (GEP-NETs) are a rare and heterogeneous group of neoplasms that originate from neuroendocrine cells in the gastrointestinal tract and pancreas. These cells produce hormones that regulate various functions in the body. GEP-NETs can be classified as functional or non-functional, depending on whether they secrete excess hormones or not. Functional GEP-NETs can cause various syndromes, such as carcinoid...